{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "HEPATITIS B IN PREGNANCY AND THE POSTNATAL PERIOD"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "12004"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "4.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Midwives, Obstetricians"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "3 August 2020"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "2 August 2023"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "National Screening Standards"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "11, 12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Women's and Children's"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Emma Neate, Antenatal and Newborn Screening Co-ordinator"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2610 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2612 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Miss Rao, Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "9 July 2020"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "July 2020"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612Trust Intranet \u2612Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Miss Thakur"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Mr Gangooly"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Mr Partington"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Mr Spencer"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Miss Sharma"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Mr Fiadjoe"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Miss Joshi"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Miss Dutta"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Miss Kausar"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Dr Hassan"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Ros Bullen-Bell"
                    },
                    {
                        "text": "Head of Midwifery"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Diane Whybro"
                    },
                    {
                        "text": "Senior Midwife Antenatal Clinic"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Lavina D'Souza"
                    },
                    {
                        "text": "Lead Midwife for Antenatal Clinic and Gynaecology Services"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Amanda Dixon"
                    },
                    {
                        "text": "Labour Ward Manager and Lead Midwife for Acute Inpatient Services"
                    },
                    {
                        "text": "18 June 2020"
                    },
                    {
                        "text": "Angela Woolfenden"
                    },
                    {
                        "text": "Lead Midwife for Community Services"
                    },
                    {
                        "text": "18 June 2020"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text) 04071 Standard Infection Prevention 04072 Hand Hygiene 06036 Guideline for Maternity Record Keeping including Documentation in Handheld Records 06031 Receiving and Communicating Test Results in Maternity by both Hospital and Community 09062 Maternity Care 09127 Interpreting and Translating Policy 08056 Guideline for the management of HIV in pregnancy 08045 Management of amniocentesis for antenatal diagnosis 07011 Confidentiality Policy"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 8,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/ Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Nicky Leslie"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Feb 2012"
                    },
                    {
                        "text": "1.1"
                    },
                    {
                        "text": "Nicky Leslie"
                    },
                    {
                        "text": "Neonatal Alert form"
                    },
                    {
                        "text": "July 2012"
                    },
                    {
                        "text": "1.2"
                    },
                    {
                        "text": "Nicky Leslie"
                    },
                    {
                        "text": "Clarification to point 6.0, 7.0"
                    },
                    {
                        "text": "Feb 2013"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Nicky Leslie"
                    },
                    {
                        "text": "Full Review"
                    },
                    {
                        "text": "March 2015"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Emma Neate"
                    },
                    {
                        "text": "Full Review"
                    },
                    {
                        "text": "16 June 2018"
                    },
                    {
                        "text": "4.0"
                    },
                    {
                        "text": "Emma Neate"
                    },
                    {
                        "text": "Full Review, Clarification to points 3.0, 5.0, 13.0, 16.0, 20.0 and 21.0"
                    },
                    {
                        "text": "3 August 2020"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "Contents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose ....................................................................................................................... 5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality Impact Assessment ..................................................................................... 5 3 Roles and Responsibilities\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..............5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Rationale ..................................................................................................................... 6"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "What is Hepatitis B ..................................................................................................... 7"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Routine Screening in Antenatal Clinic ...................................................................... 8"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Sexual Health and Prevention of Infections in Pregnancy ..................................... 9"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Declining Screening ................................................................................................... 9"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Failsafe of Screening Results.................................................................................. 10 10 Women Presenting in Labour without Antenatal Screening Blood Results........ 10"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Management of ResultsAntenatal Management of Hepatitis B Positive"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 1,
                "text": "Mothers ............................................................................................................................. 11"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "12 Women who miscarry of Terminate their Pregnancy following Screening. ........ 11 13 Action to be taken for women who move out of the area\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026........11 14 Antenatal Management of Hepatitis B Positive Mothers .....\u2026\u2026\u2026\u2026\u2026\u2026...\u2026......12 15 HIV and Hepatitis B and C Co-infected Patients\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026......14 16 Intrapartum Management \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...\u2026......."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Neonatal Management .............................................................................................  Staff and Training \u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.........17 19 Infection Prevention \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026........  Audit and Monitoring \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026........  Approval and Implementation\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026......18 22 References \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026........ Appendix A: Antenatal and Newborn Screening SOP\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026......20 Appendix B: Hepatology Referral Form \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026......\u202622 Appendix C: Management of Hepatitis B Positive Women in Pregnancy\u2026\u2026\u2026......."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 1,
                "prefix": 27.0,
                "text": "Appendix D: Neonatal Alert Form \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026........\u2026 Appendix E: Out of Hours Standard Operating Procedure\u2026\u2026\u2026\u2026\u2026\u2026..\u2026....\u2026.......26 Appendix F: Preliminary Equality Analysis \u2026\u2026\u2026\u2026\u2026\u2026\u2026.......\u2026\u2026\u2026\u2026\u2026...\u2026........."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "text": "Hepatitis B in Pregnancy and the Postnatal Period / 12004 / 4.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 1,
                "prefix": 28.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "To provide a guideline on the management of hepatitis B in pregnancy and to prevent perinatal transmission from mother to baby; as hepatitis B can have serious maternal and neonatal consequences."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality Impact Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "Mid and South Essex NHS Foundation Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals. (Refer to Appendix 1)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "All women accessing care at Broomfield Hospital Maternity Unit have the same"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "text": "access to screening, subsequent diagnostic testing and outcomes in line with"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "text": "the Equality Act 2010."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "prefix": 2.3,
                "text": "The Trust has procedures in place to identify and support those persons who"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "text": "are considered vulnerable/ hard-to-reach including:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "text": "Those who are not registered with a GP;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "text": "Homeless people / rough sleepers;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "text": "Asylum seekers;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "text": "Gypsy and traveller groups;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "text": "Sex workers;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "text": "Those in prison;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "text": "Those with mental health problems;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "text": "Those with drug or alcohol harm issues;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "text": "Those with learning disabilities;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "text": "Physical disabilities or communications difficulties."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Roles and Responsibilities"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "The Specialist Nurse for Guidelines and Audit is responsible for ensuring clinical policies, guidelines and SOPs, are evidence-based and developed in line with national guidelines and following appropriate consultation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "prefix": 3.2,
                "text": "The clinical director is responsible for the implementation of this guideline within the directorate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "prefix": 3.3,
                "text": "The Head of Midwifery, maternity matrons and maternity managers are responsible for ensuring maternity staff are aware of the guideline and implement it."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "prefix": 3.4,
                "text": "The Obstetric Clinical Lead Consultant, the Antenatal Ward Lead Consultant and the Labour Ward Lead Consultant are responsible for ensuring the implementation of this guideline within the clinical setting."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "prefix": 3.5,
                "text": "All maternity staff are responsible for ensuring they are familiar with this guideline in relation to their practice and have the appropriate skills to implement this guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Rationale"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "The aim of pregnancy screening is to contribute to the reduction of perinatal Hepatitis B infection. The risk of perinatal transmission is dependent on the status of the maternal infection. About 70 - 90% of babies born to mothers who are positive for both HB surface antigen (HBsAg) and HB e-antigen will become chronically infected (without immunisation)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "The rate of chronic infection is less than 10% in babies born to women positive for HBsAg and antibody to e antigen (AntiHBe). It is recognised that, without intervention, the earlier in life the infection occurs the greater the risk that it will lead to chronic infection, liver disease and early death."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "Immunisation of the baby within 24 hours of delivery, and at 1, 2 and  months has been shown to be effective in preventing transmission of infection from mother to baby. In babies born to women with a higher risk of transmission, the addition of Hepatitis B Specific Immune Globulin (HBIG) can help reduce the risk further."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "Since August 2017, all babies receive additional Hepatitis B vaccination; as part of the newly introduced Hexavalent vaccine schedule. This means that babies born to mothers with Hepatitis B will now receive 6 Hepatitis B vaccines in the first year of life, including the follow-up blood test at 1 year."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "With this strategy, transmission can be prevented in over 90% of babies exposed to maternal infection."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "prefix": 4.6,
                "text": "The objectives of the screening programme are to:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "text": "Ensure that all HBV positive women are identified;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "text": "Provide counselling and support and where appropriate, testing and immunisation to the family;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "text": "Refer all HBV positive women for assessment and management by an appropriate specialist (e.g. a hepatologist / gastroenterologist) within 6 weeks of the screening test result being received by maternity services even if the woman has already been referred previously and is being followed up/getting treatment as they may be unaware of her pregnancy and the management plan may need to be reviewed;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "Ensure that the infant immunisation schedule is offered for their babies, that the first dose is administered within  hours of delivery and that arrangements for completion of the schedule are initiated."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "What is Hepatitis B?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Hepatitis B is an infectious inflammatory illness of the liver caused by the hepatitis B virus (HBV). The virus can follow a variable course with two possible phases; acute and chronic."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "text": "5.1.1 Acute Hepatitis B refers to newly acquired infections. Affected individuals notice symptoms approximately 1 to 4 months after exposure to the virus. In people who acquire infection during adulthood, around 90% will clear the infection spontaneously after several weeks. They are cured of the infection, are no longer infectious to others and are immune to re-infection. Those who do not clear the virus spontaneously develop chronic hepatitis B and a smaller number develop a very severe, life-threatening form of acute hepatitis called \u2018fulminant hepatitis'."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "text": "5.1.2 Chronic Hepatitis B refers to infections which fail to clear within 6 months. The risk of progression to chronic hepatitis B is inversely proportional to the age infection is acquired, with over 90% of infected infants becoming chronically infected. Once the infection becomes chronic it is unlikely to resolve and the person affected then becomes a lifelong carrier. Approximately 20% of chronic carriers will develop cirrhosis (permanent scarring of the liver) over a period of years, dramatically increasing their risk of developing primary liver cancer."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Hepatitis B is very infectious and is present in all body fluids such as blood, semen, vaginal secretions and saliva. It can be transmitted through unprotected sexual intercourse, direct contact with the blood of an infected person, sharing infected needles and from a mother to her baby during birth (perinatal transmission). Globally, perinatal transmission, from mother to baby, is the most common route of transmission. Hepatitis B infection is preventable by vaccination."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 1,
                "prefix": 5.3,
                "text": "Hepatitis B in pregnancy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "text": "5.3.1 Babies born to mothers with Hepatitis B are at high risk of acquiring HBV infection, particularly if the mother has a high level of HBV DNA (viral load) and displays hepatitis B \u2018e' antigen positivity (HBeAg) in her plasma. The risk of transmission depends on the status of the maternal infection. Without intervention, 70 to 90% of mothers who are \u2018e' antigen positive (HBeAg) will pass the infection to their baby compared to a 10% risk for mothers who are \u2018e' antigen negative."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "text": "5.3.2 Perinatal transmission can result in an acute or chronic infection, but babies have a much higher chance of being chronically infected. Without vaccination, 95% will have a sub-clinical infection (rather than acute hepatitis) and many become chronic carriers for life. This population has a 40% lifetime risk of death from cirrhosis or liver cancer."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "text": "5.3.3 The development of chronic infection after perinatal transmission can be prevented in over 90% of cases by timely vaccination (hepatitis B vaccine +/- hepatitis B immunoglobulin (HBIG)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "text": "5.3.4 The mode of delivery and breastfeeding does not affect mother to child transmission if the baby receives appropriate management."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Routine Screening in Antenatal Clinic"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Screening is a process of identifying apparently healthy people who may be at increased risk of a disease or condition. They can then be offered information, further tests and appropriate treatment to reduce their risk and/or any complications arising from the disease or condition."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "The UK National Screening Committee (UK NSC) recommends that systematic, population screening in pregnancy is offered and recommended to all eligible women for:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "text": "Human immunodeficiency virus (HIV);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "text": "Syphilis;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "text": "Hepatitis B."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "Informed consent must be obtained prior to the specimen being taken."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 1,
                "prefix": 6.4,
                "text": "All pregnant women should be provided with written information \u2018Screening tests for you and your baby' prior to their booking appointment. This is"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "available in English and  other languages, via www.gov.uk/government/publications/screening-tests-for-you-and-your-"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "text": "baby-description-in-brief ."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "prefix": 6.5,
                "text": "For women who do not have English as a first language, they must be offered interpreting services to help them make an informed choice about screening. It is not acceptable to use friends or family to translate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 0,
                "prefix": 6.6,
                "text": "For women with learning disabilities, physical disabilities or communication difficulties provisions should be made by Maternity services to ensure that these individuals have access to information and care."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 1,
                "prefix": 6.7,
                "text": "When the midwife completes the woman's booking and discusses the various blood tests; bloods must be taken at booking or within 5 days for the booking (where not possible at booking). The booking midwife should review the blood results within 10 days of the sample being taken and for them to follow up with women for samples to be taken or repeated where required."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "prefix": 6.8,
                "text": "The midwife should clearly document whether the screening has been accepted or declined and whether a blood sample has been obtained in the handheld notes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 0,
                "text": "6.8.1  At the antenatal booking women should be asked if the baby will be exposed to anyone in the household who is Hepatitis B positive, if they inform the midwife of another person in the home who is positive and the woman is negative; the screening team need to be informed and a neonatal alert completed for the baby to have vaccination following delivery."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "prefix": 18.0,
                "text": "\u2018Newborn infants born to a hepatitis B negative woman but known to be going home to a household with another hepatitis B infected person may be at immediate risk of Hepatitis B infection. In these situations, a monovalent dose of hepatitis B vaccine should be offered before discharge from hospital. They should then continue on the routine childhood schedule commencing at eight weeks.' (Green Book, Chapter  \u2013 Hepatitis B, 2019)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 1,
                "prefix": 6.9,
                "text": "Women already known to be Hepatitis B Positive"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "text": "6.9.1 Laboratory request forms should be labelled \u2018high risk' and documentation of prior diagnosis if known"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "text": "6.9.2 The Antenatal Screening team needs to be informed of the pregnancy at the earliest opportunity to arrange a multidisciplinary team approach for care."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Sexual health and prevention of infections in pregnancy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "\uf020Women should be advised on the availability of testing at any stage of pregnancy if they feel they are at risk."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "Repeat tests should be considered in pregnancy if women"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "text": "Change their sexual partner;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "text": "Inject recreational drugs;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "text": "Are a sex worker;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "text": "Have a partner that is known to be bisexual;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "text": "Have a partner that is known to have HIV or Hepatitis;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 0,
                "text": "If either partner is diagnosed with an STI."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Declined Screening"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Where women decline screening tests, the midwife who offered the initial screening should inform the Screening Team."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "prefix": 20.0,
                "text": "Women should be contacted by the Screening team as soon as possible and ideally before  weeks to discuss their decision to decline screening and ensure that they are fully aware of the benefits of screening for infectious diseases for them and their baby."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "Reoffer the screening test and arrange testing and follow up of results."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "The onus of the reoffer is to facilitate an informed choice and not to coerce women to accept screening."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 1,
                "prefix": 8.6,
                "text": "Un-booked women / Late Bookers"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "text": "Women who book after 24 weeks of pregnancy should have blood samples marked as urgent and sent to the laboratory (Appendix F). Test results should be available within 24 hours of receipt of sample at laboratory."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Failsafe of Screening Results"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "The Failsafe Officer monitors the eligible population from their referral for care, ensuring that all women who accept screening have it performed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Maternity Phlebotomist will review all women on the daily scan list for st trimester scans, they review all the screening results and check for completion of screening \u2013 these results are checked by a Antenatal Clinic or Screening Midwife, if any results are missing; these bloods will be taken with consent after the scan."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "The Failsafe Officer will carry out a failsafe check following the woman's st trimester scan to ensure all screening results are available and to highlight any that are abnormal to the screening midwives; this acts as a failsafe for abnormal results also. If any results are found to be missing, the following steps are followed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 0,
                "text": "Screening team will send one letter to the woman regarding the need to have bloods taken;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 0,
                "text": "Screening team will develop a missing bloods list \u2013 send to ANC, WJC, St Peter's, Chelmsford community team each month and for the teams to contact and arranging screening for the women within the following 2 weeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 1,
                "prefix": 9.4,
                "text": "Reporting Incidents within the Screening Programme"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 1,
                "text": "9.4.1  Any incidents related to the screening pathway / programme need to be datixed via the Trust's incident reporting system, the Screening Coordinator / Deputy will review the Datix and if the incident meets the Antenatal and Newborn Screening Incident Criteria then an alert is sent by the Screening Team or Governance team to Public Health England (See Women's and Children's Division Clinical Governance Structure Policy 05098,Appendix B)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Women Presenting in Labour without an Antenatal Screening Blood Result"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Women presenting in labour, who have not been previously for antenatal care, at the Trust are recommended to be offered testing for HIV, Hepatitis B, and Syphilis on first contact. The sample should be marked as urgent. See Appendix D for Out of Hours Screening"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Management of results"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 1,
                "prefix": 11.1,
                "text": "Screen negative results:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "text": "All women should be notified of their screening test result before or at the next antenatal visit. The result should be recorded in the health records;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "text": "The healthcare professional notifying the woman of her negative result should inform the woman that she was negative at the time of testing and offer the woman sexual health advice. She should be informed that she can request screening at any stage in her pregnancy if she deems herself at risk or changes her sexual partner."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 1,
                "prefix": 11.2,
                "text": "Confirmed screen positive results:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "text": "The laboratory will directly inform the Antenatal Screening Team of the screen positive result; this is done via the screening generic email address"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 0,
                "text": "\u2013 Antenataland.newbornscreening@nhs.net and via phone ext 3433. (See Antenatal Management of Hepatitis B Positive Mothers section)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 1,
                "prefix": 11.3,
                "text": "Inconclusive results:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "text": "The Screening Team will contact the woman and inform her of the inconclusive result and the need for a repeat sample within 2 weeks after the initial sample was taken to exclude recent infection."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Women who miscarry or terminate their pregnancy following screening"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "Screen positive- The Screening Team will write to the woman within  working days of the positive result to facilitate appropriate onward referral into specialist services and close the maternity care episode."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "Screen negative- The Screening Team will write to the woman to inform her of her negative results for her screening tests."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Action to be taken for women who move out of the area"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "The screening team will keep a record of all pregnant Hepatitis B women. If these women move out of area the local midwife should advice the Screening team so that a clear record can be kept."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Antenatal Management of Hepatitis B Positive Mothers"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "As part of the clinical pathway and follow-on care, further tests are required to assess infectivity and will identify Hepatitis B antigens and antibodies and measure the maternal viral load (HBV DNA). These antigens and antibodies are known as viral or \u2018e markers'. Testing for \u2018e'markers and measuring a person's viral load over the course of infection gives an indication of how the infection is progressing and/or if it is responding to treatment. In particular, finding the \u2018surface' and \u2018e' antigens (known as HBsAg and HBeAg) and their corresponding antibodies is very important in establishing the pattern of disease."
            }
        },
        {
            "type": "table",
            "sequence_num": 130,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Antigens (and HBV DNA)"
                    },
                    {
                        "text": "Are parts of the virus. They are a sign that someone has hepatitis B and may infect others."
                    },
                    {
                        "text": "Antibodies"
                    },
                    {
                        "text": "Are created by the immune system to fight the virus. Antibodies are not infectious."
                    },
                    {
                        "text": "HBs Antigen (HBsAg): surface antigen"
                    },
                    {
                        "text": "The term \u2018surface' refers to the outer surface of the virus itself. It appears 1 to 2months after infection and disappears from the blood as the infection clears (World Health Organisation 2015). A positive result indicates that someone has acute or chronic hepatitis B. A negative result shows that a person has either never been exposed to the virus or that they have recovered from the infection and have rid themselves of the virus. If HBsAg disappears and protective antibodies appear (HBsAg negative, anti-HBs positive), this is considered a \u201ccure\u201d."
                    },
                    {
                        "text": "HBs antibody (anti-HBs)"
                    },
                    {
                        "text": "The immune system creates this antibody to destroy the HBsAg of the virus. Anti-HBs appear if an infected person clears their virus (\u201ccure\u201d), or if a healthy person is successfully vaccinated. The HBs antibody also makes a person immune against hepatitis B, so they cannot be re-infected with hepatitis B."
                    },
                    {
                        "text": "HBV DNA (viral load)"
                    },
                    {
                        "text": "This important test does not look for antigens or antibodies but monitors the amount of virus in the blood, known as the \u2018viral load'. Viral load is an indicator of infectivity. The higher the viral load, the more infectious the infected person will be. A high viral load is considered as equal to or above 1x106 IUs/ml in"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 131,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "an antenatal blood sample. A high viral Load also increases the risk of cirrhosis and liver cancer. A very low amount or no trace of the virus is a marker of an individual's good immune response to the virus or a good response to antiviral medication in a person who is receiving treatment. The specialist liver team will interpret this result."
                    },
                    {
                        "text": "HBc antibody (anti-HBc)"
                    },
                    {
                        "text": "This antibody is created by the immune system against the core of the hepatitis B virus. It always becomes positive in an infection and stays for life, no matter whether the infection is cleared or becomes chronic. Anti-HBc does not appear in healthy vaccinated patients. Its presence shows that a real infection has occurred or is still present."
                    },
                    {
                        "text": "HBe antigen (HBeAg)"
                    },
                    {
                        "text": "E antigen positivity is a sign that the virus is actively replicating. The viral load(HBV DNA) is usually very high in these patients. Together a high viral load and \u2018e' antigen positivity indicate that a person is highly infectious and can infect others easily. However, HBeAg is also a vulnerable part of the virus. The immune system might create anti-HBe antibodies (anti-HBe) which can negate the \u2018e' antigen. This is called HBeAg seroconversion. This is not a cure, but \u2018e' antigen negativity means the virus is being controlled by the immune system so it cannot replicate as rapidly."
                    },
                    {
                        "text": "HBe antibody (anti-HBe)"
                    },
                    {
                        "text": "This is created by the immune system to destroy the HBe antigen. It is present in people recovering from an acute hepatitis B infection. E antibody positivity in chronic hepatitis B infection suggests lower levels of the virus are likely to be present in the blood."
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "High risk blood results should be referred to the Antenatal Screening team, who will contact the women and arrange an appointment to discuss results face to face within  working days."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 0,
                "prefix": 14.3,
                "text": "A second blood sample is required to confirm a Hepatitis B positive result, if this is a new diagnosis at the initial contact. Women seen by the Screening team, requiring a second confirmatory blood sample to be taken, should also have a blood sample taken for full Hep B serology profile (Hepatitis B Surface Antigen, Hepatitis B core antigen and core antibody, Hepatitis B e antigen, e antibody), HBV DNA PCR, HDV serology ( Hepatitis D Virus Serology) this will then allow the gastroenterology team to review the blood results at the first hepatologist appointment."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 0,
                "prefix": 14.4,
                "text": "All women requiring second confirmatory blood samples will be referred to the gastroenterology team (see Appendix B), for counselling, appropriate testing and  assessment.  This  form  is  also  sent  to  Essex  Immunisation  Team (PROVIDE) informing of a Positive result."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 0,
                "prefix": 14.5,
                "text": "Where women are having repeat blood tests for infectious diseases during pregnancy the request repeat must be indicated, so that it can be identified as second sample to the laboratory. All confirmed screening test results should be received by the maternity services and women seen within 10 working days of the repeat specimen being taken- as per the National Programme Standards."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 0,
                "prefix": 14.6,
                "text": "All Hepatitis B Positive Women are referred for assessment and management by a gastroenterologist within 6 weeks of the screening test result being received by maternity services, as per National Screening Programmes standards. (Refer to Appendices A and B). The Gastroenterologist will make a plan of care and send this to the screening team regarding whether medication is required."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 0,
                "prefix": 14.7,
                "text": "If the woman should be referred to the Obstetric Consultant lead for Infectious Diseases for an appointment around 16-20 weeks -or as soon as possible if referring later in pregnancy- for review and obstetric plan of care."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 0,
                "prefix": 14.8,
                "text": "The Antenatal Screening team will complete the proforma for the management of Hepatitis B positive woman in pregnancy. (Refer to Appendix C)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 0,
                "prefix": 14.9,
                "text": "The women's named midwife and GP should be informed to provide additional support for the woman."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "A neonatal alert form should be completed and sent to the Antenatal Screening team located in the Antenatal Clinic, who will photocopy the alert form for her records. Screening Midwife will forward the neonatal alert form to the named consultant paediatrician for a plan of care post-delivery. (Refer to Appendix D)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 0,
                "prefix": 14.11,
                "text": "Hepatitis B vaccine is kept as a stock item on Delivery Suite. Babies also prescribed Immunoglobulin will have the completed prescription chart sent to pharmacy, to allow the prescription to be stored on the neonatal unit drug fridge prior to the birth of the baby."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 0,
                "prefix": 14.12,
                "text": "When the named Paediatric Consultant has completed the neonatal alert form with a care plan, a copy will be retained in the neonatal folder. A further copy will be sent to the Screening team; who will then provide a subsequent copy for the Labour Ward folder. Screening team will provide a copy which should be filed in the patient's lilac folder."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 0,
                "prefix": 14.13,
                "text": "Invasive prenatal testing in the first or second trimester can be carried out in patient who carry Hepatitis B or C. (Refer to the guideline entitled \u2018Management of amniocentesis for antenatal diagnosis'; register number 08045)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 144,
            "data": {
                "is_heading": 1,
                "prefix": 14.14,
                "text": "Offer tenofovir disoproxil to women with HBV DNA greater than 107 IU/ml in the third trimester to reduce the risk of transmission of HBV to the baby. Discuss with pregnant women the benefits and risks of antiviral treatment for them and their baby.This plan is made by the Gastroenterology Team only."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 145,
            "data": {
                "is_heading": 0,
                "prefix": 14.15,
                "text": "Women who may be at above average risk of transmission (i.e. those who have previously infected an infant during childbirth) may be offered antiviral therapy (as above) with or without HBIg. The risks and benefits and the limited evidence for this approach should be discussed with the patient."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 0,
                "prefix": 14.16,
                "text": "In line with MEHT guidance, patient confidentiality must be adhered to. Documentation in the handheld records, including printed blood results must be with woman's consent. All other documentation must be placed in the hospital records. (Refer to \u2018Confidentiality Policy'; register number 07011)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 0,
                "prefix": 14.17,
                "text": "Patient Information Leaflets for Women who are Hepatitis B positive are available from the following link:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 0,
                "text": "https://assets.publishing.service.gov.uk/government/uploads/system/uploads/att achment_data/file/699472/Hepatitis_B_what_does_my_positive_screening_res ult_mean_110418.pdf"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 149,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "HIV and Hepatitis B and C Co-infected Patients"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 150,
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "All co-infected women should be treated with combination antiretroviral therapy i.e. highly active anti retroviral therapy (HAART), short term anti-retroviral therapy (START). Women co-infected with Hepatitis B should be treated with a combination which includes drugs with activity against Hepatitis B. Women co- infected with Hepatitis C should be offered elective (lower segment caesarean section) LSCS."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Intrapartum Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 152,
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "Each case should be reviewed on an individual basis by an Obstetrician. Any antenatal discussion and planning of care in labour should be noted."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 153,
            "data": {
                "is_heading": 1,
                "prefix": 16.2,
                "text": "Elective caesarean delivery as a means of reducing mother to child transmission, this mode of delivery does not appear to have a significant effect on vertical transmission of the Hepatitis B virus."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 154,
            "data": {
                "is_heading": 0,
                "prefix": 16.3,
                "text": "The delivery should be managed to minimise the risk of vertical transmission, by avoiding fetal blood sampling and foetal scalp electrodes in most circumstances."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 155,
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Neonatal Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 156,
            "data": {
                "is_heading": 0,
                "text": "(Refer to the guideline for the administration of Hepatitis B in neonates'; register number)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 157,
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "The Delivery Suite Midwife / Postnatal ward Midwives are responsible for ensuring that the Neonatal Doctors prescribe and administer the Hepatitis B vaccine and (where applicable) Immunoglobulin, as soon as possible after birth (within 24 hours)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 158,
            "data": {
                "is_heading": 1,
                "prefix": 17.2,
                "text": "Antenatal Hepatitis B results must be checked before any vaccination or immunoglobulin is prescribed."
            }
        },
        {
            "type": "image",
            "sequence_num": 159,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.003.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 160,
            "data": {
                "is_heading": 0,
                "text": "Taken from the Green Book \u2013 2013, https://assets.publishing.service.gov.uk/government/uploads/system/uploads/att achment_data/file/628602/Greenbook_chapter__18.pdf"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 161,
            "data": {
                "is_heading": 1,
                "text": "Current immunisation schedule"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 162,
            "data": {
                "is_heading": 0,
                "prefix": 17.3,
                "text": "Where  a  pregnant  woman  is  identified  through  the  screening  process  as infected with HBV, The Department of Healthcurrently recommends the baby is vaccinated using the accelerated schedule comprising of vaccinations given:"
            }
        },
        {
            "type": "image",
            "sequence_num": 163,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.004.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 164,
            "data": {
                "is_heading": 0,
                "text": "Taken from the Green Book \u2013 2013, https://assets.publishing.service.gov.uk/government/uploads/system/uploads/att achment_data/file/628602/Greenbook_chapter__18.pdf"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 165,
            "data": {
                "is_heading": 0,
                "prefix": 17.4,
                "text": "Timely administration of vaccines is always important; however, for Hepatitis B vaccinations it is crucial. A complete course is required for full protection. Even the timely administration of the full course of vaccinations will not stop infection in all cases. However, where administered in line with the Green Book schedule, targeted immunisation can prevent persistent hepatitis B infection"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 166,
            "data": {
                "is_heading": 1,
                "prefix": 17.5,
                "text": "Antenatal Hepatitis B results must be checked before vaccination or immunoglobulin is prescribed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 167,
            "data": {
                "is_heading": 0,
                "prefix": 17.6,
                "text": "A Paediatric Consultant will take responsibility for the management of the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 168,
            "data": {
                "is_heading": 0,
                "text": "neonate in collaboration with the Obstetrician. The Paediatrician should already be aware of the delivery."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 169,
            "data": {
                "is_heading": 0,
                "prefix": 17.7,
                "text": "For women who are HBeAg negative the infant should receive active vaccination after delivery i.e. the infant should receive a vaccine based on HBsAg."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 170,
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "For women who are HBeAg positive the infant should receive both active and passive vaccination after delivery i.e. the infant should receive a vaccine based on HBsAg and Hepatitis B immunoglobulin. (If required this would be ordered by Neonatal Consultant at 32/40+ stored in NICU drug fridge). Both drugs should be administered within  Hrs of birth."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 171,
            "data": {
                "is_heading": 0,
                "prefix": 17.8,
                "text": "Current Immunisation Schedule - clear documentation in:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 172,
            "data": {
                "is_heading": 0,
                "text": "Baby's notes;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 173,
            "data": {
                "is_heading": 0,
                "text": "Drug chart;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 174,
            "data": {
                "is_heading": 0,
                "text": "Child health record book;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 175,
            "data": {
                "is_heading": 0,
                "text": "Immunisation notification form;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 176,
            "data": {
                "is_heading": 0,
                "text": "Discharge summary."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 177,
            "data": {
                "is_heading": 0,
                "text": "This to be emailed to \u2013 provide.childhealth@nhs.net (Appendix C)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 178,
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Staffing and Training"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 179,
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "All midwifery and obstetric staff must attend yearly mandatory training which includes maternal antenatal screening tests."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 180,
            "data": {
                "is_heading": 0,
                "prefix": 18.2,
                "text": "All midwifery and obstetric staff are to ensure that their knowledge and skills are up-to-date in order to complete their portfolio for appraisal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 181,
            "data": {
                "is_heading": 1,
                "prefix": 18.3,
                "text": "Guideline Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 182,
            "data": {
                "is_heading": 0,
                "text": "18.3.1 As an integral part of the knowledge, skills framework, staff are appraised annually to ensure competency in computer skills and the ability to access the current approved guidelines via the Trust's intranet site."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 183,
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Infection Prevention"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 184,
            "data": {
                "is_heading": 0,
                "prefix": 19.1,
                "text": "All staff should follow Trust guidelines on infection prevention by ensuring that they effectively \u2018decontaminate their hands' before and after each procedure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 185,
            "data": {
                "is_heading": 0,
                "prefix": 19.2,
                "text": "All staff should ensure that they follow Trust guidelines on infection prevention. All invasive devices must be inserted and cared for using High Impact Intervention guidelines to reduce the risk of infection and deliver safe care. This care should be recorded in the Saving Lives High Impact Intervention Monitoring Tool Paperwork (Medical Devices)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 186,
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Audit and Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 187,
            "data": {
                "is_heading": 0,
                "prefix": 20.1,
                "text": "Audit of compliance with this guideline will be considered on an annual audit basis in accordance with the Clinical Audit Strategy and Policy (register number 08076), the Corporate Clinical Audit and Quality Improvement Project Plan and the Maternity annual audit work plan; to encompass national and local audit and clinical governance identifying key harm themes. The Women's and Children's Clinical Audit Group will identify a lead for the audit."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 188,
            "data": {
                "is_heading": 0,
                "prefix": 20.2,
                "text": "As a minimum the following specific requirements will be monitored:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 189,
            "data": {
                "is_heading": 0,
                "text": "Designated lead for antenatal screening in the maternity service;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 190,
            "data": {
                "is_heading": 0,
                "text": "Antenatal screening tests, which follow the UK National Screening Committee guidance;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 191,
            "data": {
                "is_heading": 0,
                "text": "System for ensuring that appropriate tests are undertaken within appropriate timescales;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 192,
            "data": {
                "is_heading": 0,
                "text": "System for ensuring that appropriate tests are undertaken when patients book late;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 193,
            "data": {
                "is_heading": 0,
                "text": "Process for the review of the results;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 194,
            "data": {
                "is_heading": 0,
                "text": "Process for reporting all results to patients;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 195,
            "data": {
                "is_heading": 0,
                "text": "Process for reporting results to other relevant healthcare professionals;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 196,
            "data": {
                "is_heading": 0,
                "text": "Process for ensuring that women with screen positive test results are referred and managed within appropriate timescales;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 197,
            "data": {
                "is_heading": 0,
                "text": "Maternity service's expectations for staff training, as identified in the training needs analysis;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 198,
            "data": {
                "is_heading": 0,
                "text": "Process for audit, multidisciplinary review of results and subsequent monitoring of action plans."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 199,
            "data": {
                "is_heading": 0,
                "prefix": 20.3,
                "text": "A review of a suitable sample of health records of patients to include the minimum requirements as highlighted in point 17.2 will be audited. A minimum compliance 75% is required for each requirement. Where concerns are identified more frequent audit will be undertaken."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 200,
            "data": {
                "is_heading": 0,
                "prefix": 20.4,
                "text": "The findings of the audit will be reported to and approved by the Multi- disciplinary Risk Management Group (MRMG) and an action plan with named leads and timescales will be developed to address any identified deficiencies. Performance against the action plan will be monitored by this group at subsequent meetings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 201,
            "data": {
                "is_heading": 0,
                "prefix": 20.5,
                "text": "The audit report will be reported to the monthly Directorate Governance Meeting (DGM) and significant concerns relating to compliance will be entered on the local Risk Assurance Framework."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 202,
            "data": {
                "is_heading": 0,
                "prefix": 20.6,
                "text": "Key findings and learning points from the audit will be submitted to the Patient Safety Group within the integrated learning report."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 203,
            "data": {
                "is_heading": 0,
                "prefix": 20.7,
                "text": "Key findings and learning points will be disseminated to relevant staff."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 204,
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Approval and Implementation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 205,
            "data": {
                "is_heading": 0,
                "prefix": 21.1,
                "text": "All policies, procedures and guidelines will be circulated clinically and professional approval confirmed by the Asset Owner prior to submission to the Controlled Document team for ratification by the Joint Document Management Group."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 206,
            "data": {
                "is_heading": 0,
                "prefix": 21.2,
                "text": "It is the Guidelines and Audit Nurse's and author's responsibility to inform appropriate Maternity Services' staff of the approved policy documents when they are uploaded to the Trust's Intranet."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 207,
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 208,
            "data": {
                "is_heading": 0,
                "text": "Department of Health (2011) Hepatitis B : Pathway stages to protection : Actions, roles. Responsibilities and standards : the safest way to protect your baby."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 209,
            "data": {
                "is_heading": 0,
                "prefix": 18.0,
                "text": "Department of Health (2013) The green book. Hepatitis B Chapter"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 210,
            "data": {
                "is_heading": 0,
                "text": "UK National Screening Committee. Infectious Diseases in Pregnancy Screening Programme : Programme Standards (2010)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 211,
            "data": {
                "is_heading": 0,
                "prefix": 2012.0,
                "text": "Infectious Diseases Screening in pregnancy. Screening Pregnancy Standards 2nd Edition"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 212,
            "data": {
                "is_heading": 0,
                "prefix": 15.0,
                "text": "NHS Public Health Functions Agreement 2018-19: Service Specification No.  NHS Infectious Diseases in Pregnancy Screening Programme"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 213,
            "data": {
                "is_heading": 0,
                "text": "Hepatitis B in Pregnancy and the Postnatal Period / 12004 /4.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 214,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 215,
            "data": {
                "is_heading": 1,
                "text": "Appendix A"
            }
        },
        {
            "type": "image",
            "sequence_num": 216,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.005.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 217,
            "data": {
                "is_heading": 1,
                "text": "Antenatal and Newborn Screening \u2013 Hepatitis B Screening"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 218,
            "data": {
                "is_heading": 1,
                "text": "Standard Operating Procedure"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 219,
            "data": {
                "is_heading": 0,
                "text": "Women refer for Antenatal Care"
            }
        },
        {
            "type": "image",
            "sequence_num": 220,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.006.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 221,
            "data": {
                "is_heading": 0,
                "text": "Referral processed and initial booking appointment arranged to see Midwife \u2013 letter sent to women with information regarding their booking appointment, scan date"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 222,
            "data": {
                "is_heading": 0,
                "text": "Antenatal Booking Performed ideally before 10 weeks, screening discussed and screening offered for Haemoglobinopathy Screening. Screening tests for you and your baby booklet given"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 223,
            "data": {
                "is_heading": 1,
                "text": "Miscarried /  Screening Positive Results Screening Negative Results  Termination of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 224,
            "data": {
                "is_heading": 1,
                "text": "pregnancy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 225,
            "data": {
                "is_heading": 1,
                "text": "Copy of blood result emailed to Results reviewed by Community  Screening Team via nhs.net"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 226,
            "data": {
                "is_heading": 1,
                "text": "Midwife, results given to woman  Letter sent to  Letter sent to  email \u2013"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 227,
            "data": {
                "is_heading": 1,
                "text": "at 16 week check  woman to inform  wcoomnatanc tt o  Antenataland.newbornscreening@n"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 228,
            "data": {
                "is_heading": 1,
                "text": "of negative result"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 229,
            "data": {
                "is_heading": 1,
                "text": "hs.net and followed up with by screening  screening  phone call informing of result."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 230,
            "data": {
                "is_heading": 1,
                "text": "team  team"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 231,
            "data": {
                "is_heading": 1,
                "text": "Woman contacted and appointment arranged to see and discuss results"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 232,
            "data": {
                "is_heading": 1,
                "text": "Seen/Counselled by Screening Midwives \u2013Information Leaflet given appropriate to result, 2nd Blood sample taken for confirmatory testing and sent to the laboratory, support given to woman and plan of care made for"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 233,
            "data": {
                "is_heading": 1,
                "text": "pregnancy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 234,
            "data": {
                "is_heading": 1,
                "text": "No further action  Results \u2013  Results \u2013 Positive"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 235,
            "data": {
                "is_heading": 1,
                "text": "Negative"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 236,
            "data": {
                "is_heading": 1,
                "text": "Inform woman of results,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 237,
            "data": {
                "is_heading": 1,
                "text": "If negative result \u2013 Arrange Obstetric Consultant  If Positive result \u2013 Arrange Obstetric Consultant appointment for review, clear documentation in hand  appointment for review, clear documentation in hand held notes  held notes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 238,
            "data": {
                "is_heading": 1,
                "text": "Referral made to Gastroenterology Consultant; for plan of care / Child Health Immunisation team notified of woman, Obstetric Consultant appointment made for plan of care for pregnancy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 239,
            "data": {
                "is_heading": 1,
                "text": "Plan of care fed back to screening team from Gastroenterology team and notes / hospital records updated, neonatal alert completed and sent to Neonatal Consultant for postnatal plan of care for baby."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 240,
            "data": {
                "is_heading": 0,
                "text": "Hepatitis B in Pregnancy and the Postnatal Period / 12004 / 4.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 241,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 242,
            "data": {
                "is_heading": 0,
                "text": "Hepatitis B in Pregnancy and the Postnatal Period / 12004 / 4.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 243,
            "data": {
                "is_heading": 1,
                "text": "Neonatal Consultant aware of results \u2013Neonatal Alert Completed, filed in mothers notes and on Delivery Suite"
            }
        },
        {
            "type": "image",
            "sequence_num": 244,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.007.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 245,
            "data": {
                "is_heading": 1,
                "text": "Following Delivery, Neonatal Doctors to be called  Mother to be reminded of the need or baby to have to Delivery Suite to prescribe and administer 1st follow up vaccines, Child Health department"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 246,
            "data": {
                "is_heading": 1,
                "text": "dose of Vaccination and Immunoglobulin (if  informed of vaccine being given by Screening Team required)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 247,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 248,
            "data": {
                "is_heading": 1,
                "text": "Appendix B"
            }
        },
        {
            "type": "image",
            "sequence_num": 249,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.008.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 250,
            "data": {
                "is_heading": 1,
                "text": "Hepatology Referrals"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 251,
            "data": {
                "is_heading": 1,
                "text": "Please send all referrals to btu-tr.btuhlivernurse@nhs.net"
            }
        },
        {
            "type": "table",
            "sequence_num": 252,
            "data": {
                "num_rows": 18,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Date of referral"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Is this referral URGENT is so why?"
                    },
                    {
                        "text": "*PREGNANT PATIENT*"
                    },
                    {
                        "text": "Patient name"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Date of birth"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "NHS Number:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Hospital Number:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Address Postcode"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Telephone number"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "GP Address"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Is an interpreter required? Please state Language"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Current Medication"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Reason for Referral/History:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Current gestation:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "EDD"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Referrer's Name (consultant or midwife)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Referring Unit and Hospital"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Referrer's telephone number"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Appointment to be made before\u2026\u2026\u2026\u2026\u2026\u2026. Please can an appointment be generated inline within the 6 week KPI timeframe. If you are unable to offer an appointment within this timeframe please contact EXT 3732 as a matter of urgency."
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 253,
            "data": {
                "is_heading": 0,
                "text": "BB/JAN/20"
            }
        },
        {
            "type": "table",
            "sequence_num": 254,
            "data": {
                "num_rows": 6,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Management of Hepatitis B Positive Women in Pregnancy"
                    },
                    {
                        "text": "First Name"
                    },
                    {
                        "text": "Surname"
                    },
                    {
                        "text": "NHS No"
                    },
                    {
                        "text": "Hospital No"
                    },
                    {
                        "text": "DOB"
                    },
                    {
                        "text": "EDD"
                    },
                    {
                        "text": "Date of Diagnosis"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 255,
            "data": {
                "is_heading": 1,
                "text": "Antenatal Newborn Screening Co-ordinator"
            }
        },
        {
            "type": "image",
            "sequence_num": 256,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.009.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 257,
            "data": {
                "is_heading": 0,
                "text": "Contacted / seen by Antenatal Newborn Screening Co-ordinator  No  Yes  Second confirmatory blood sample required  No  Yes"
            }
        },
        {
            "type": "image",
            "sequence_num": 258,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.011.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 259,
            "data": {
                "is_heading": 0,
                "text": "Date Taken __________________________ Previous Diagnosis  No  Yes  Referral to GUM / Gastroenterologist  No  Yes"
            }
        },
        {
            "type": "image",
            "sequence_num": 260,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.013.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 261,
            "data": {
                "is_heading": 0,
                "text": "Consultant(s) name and contact details:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 262,
            "data": {
                "is_heading": 0,
                "text": "______________________________________________________________________________"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 263,
            "data": {
                "is_heading": 0,
                "text": "Date __________________________ Print Name  ____________________________  Signature __________________________"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 264,
            "data": {
                "is_heading": 1,
                "text": "Antenatal Care Plan"
            }
        },
        {
            "type": "image",
            "sequence_num": 265,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.016.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 266,
            "data": {
                "is_heading": 0,
                "text": "Antenatal Clinic Appointment 16-18 weeks gestation  No  Yes Neonatal Alert form completed and sent with maternal blood results  No   Yes   and prescription chart"
            }
        },
        {
            "type": "image",
            "sequence_num": 267,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.020.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 268,
            "data": {
                "is_heading": 0,
                "text": "Medication prescribed in antenatal period"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 269,
            "data": {
                "is_heading": 0,
                "text": "No  Yes  (if immunoglobulin is required)"
            }
        },
        {
            "type": "image",
            "sequence_num": 270,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.023.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 271,
            "data": {
                "is_heading": 0,
                "text": "Medication ordered from pharmacy  N / A  No  Yes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 272,
            "data": {
                "is_heading": 0,
                "text": "Date __________________________ Print Name  ____________________________  Signature __________________________"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 273,
            "data": {
                "is_heading": 1,
                "text": "Antenatal Discussion"
            }
        },
        {
            "type": "image",
            "sequence_num": 274,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.024.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 275,
            "data": {
                "is_heading": 0,
                "text": "Leaflet provided  No  Yes  Able to breast feed  No  Yes  Vaccination timeframes  No  Yes"
            }
        },
        {
            "type": "image",
            "sequence_num": 276,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.025.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 277,
            "data": {
                "is_heading": 0,
                "text": "Date __________________________ Print Name  ____________________________  Signature __________________________"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 278,
            "data": {
                "is_heading": 1,
                "text": "Postnatal Vaccinations"
            }
        },
        {
            "type": "image",
            "sequence_num": 279,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.027.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 280,
            "data": {
                "is_heading": 0,
                "text": "Prescribe Hep B Vaccine"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 281,
            "data": {
                "is_heading": 0,
                "text": "No  Yes (immunoglobulin already prescribed, if required)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 282,
            "data": {
                "is_heading": 0,
                "text": "First Hep B Vaccination as soon as possible after birth"
            }
        },
        {
            "type": "image",
            "sequence_num": 283,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.017.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 284,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "No  Yes  (within first  hours after delivery)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 285,
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "Advise follow up vaccinations at 1 month, 2 months and  months  No   Yes   after birth"
            }
        },
        {
            "type": "image",
            "sequence_num": 286,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.023.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 287,
            "data": {
                "is_heading": 0,
                "text": "Document in the personal child health record, page 4  No  Yes  Date __________________________"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 288,
            "data": {
                "is_heading": 0,
                "text": "Print Name  ____________________________  Signature __________________________"
            }
        },
        {
            "type": "image",
            "sequence_num": 289,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.001.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 290,
            "data": {
                "is_heading": 1,
                "text": "Appendix D"
            }
        },
        {
            "type": "table",
            "sequence_num": 291,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Neonatal Alert Form"
                    },
                    {
                        "text": "First Name"
                    },
                    {
                        "text": "Surname"
                    },
                    {
                        "text": "NHS No"
                    },
                    {
                        "text": "Hospital No"
                    },
                    {
                        "text": "Referral Date"
                    },
                    {
                        "text": "EDD"
                    },
                    {
                        "text": "Gestation"
                    },
                    {
                        "text": "Consultant"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 292,
            "data": {
                "is_heading": 1,
                "text": "Background history & problem summary"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 293,
            "data": {
                "is_heading": 1,
                "text": "Delivery Plans"
            }
        },
        {
            "type": "image",
            "sequence_num": 294,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.028.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 295,
            "data": {
                "is_heading": 0,
                "text": "Broomfield Hospital  Not Decided"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 296,
            "data": {
                "is_heading": 0,
                "text": "Other Hospital   _____________________________________"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 297,
            "data": {
                "is_heading": 1,
                "text": "Neonatal Alert Form Criteria"
            }
        },
        {
            "type": "image",
            "sequence_num": 298,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.029.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 299,
            "data": {
                "is_heading": 0,
                "text": "Please use the neonatal alert form for the following conditions:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 300,
            "data": {
                "is_heading": 0,
                "text": "Multiple pregnancy (higher order > 2  \uf0b7  Severe oligohydramnios / IUGR fetus)  \uf0b7  Abnormal dopplers"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 301,
            "data": {
                "is_heading": 0,
                "text": "Hepatitis B in Pregnancy and the Postnatal Period / 12004 / 4.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 302,
            "data": {
                "is_heading": 1,
                "prefix": 28.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 303,
            "data": {
                "is_heading": 0,
                "text": "Hepatitis B positive mother"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 304,
            "data": {
                "is_heading": 0,
                "text": "HIV positive mother"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 305,
            "data": {
                "is_heading": 0,
                "text": "Previous baby with GBBS sepsis / meningitis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 306,
            "data": {
                "is_heading": 0,
                "text": "Significant structural abnormalities diagnosedon ultrasound scan"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 307,
            "data": {
                "is_heading": 0,
                "text": "Genetic / hereditary conditions in the immediate family that may affect the fetus"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 308,
            "data": {
                "is_heading": 0,
                "text": "Social e.g. drug abuse, alcohol abuse in this pregnancy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 309,
            "data": {
                "is_heading": 0,
                "text": "Any other condition that will require paediatric input at birth"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 310,
            "data": {
                "is_heading": 0,
                "text": "All cases that require referral to specialist units for treatment or advice"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 311,
            "data": {
                "is_heading": 0,
                "text": "Mothers with high antibody titres e.g. Anti-D, C and Kell"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 312,
            "data": {
                "is_heading": 1,
                "text": "Postnatal Plan (paediatric)"
            }
        },
        {
            "type": "image",
            "sequence_num": 313,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.030.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 314,
            "data": {
                "is_heading": 0,
                "text": "Designation  ____________________  Date ________________________  Print Name  ____________________  Signature ________________________"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 315,
            "data": {
                "is_heading": 1,
                "text": "Appendix E"
            }
        },
        {
            "type": "image",
            "sequence_num": 316,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.031.png"
            }
        },
        {
            "type": "image",
            "sequence_num": 317,
            "data": {
                "url": "12004 Hepatitis in pregnancy and the postnatal period 4.0.032.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 318,
            "data": {
                "is_heading": 1,
                "text": "Appendix F: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 319,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Hepatitis B in Pregnancy and the Postnatal Period / 12004"
            }
        },
        {
            "type": "table",
            "sequence_num": 320,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2612 A change to an existing policy"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2610 A new policy"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 321,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Update and review of Guideline in Line with the National Screening Standards and Specifications"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Update and review of Guideline in Line with the National Screening Standards and Specifications"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Maternity MDT"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "See pages 1 and 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 322,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Emma Neate"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Screening Co-ordinator"
                    },
                    {
                        "text": "24 June 2020"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 323,
            "data": {
                "is_heading": 1,
                "text": "If you have identified any negative impact in the preliminary analysis above, please request and complete the full Equality Impact Assessment (EIA) from Document Control."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 324,
            "data": {
                "is_heading": 0,
                "text": "Hepatitis B in Pregnancy and the Postnatal Period / 12004 / 4.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 325,
            "data": {
                "is_heading": 1,
                "prefix": 28.0,
                "text": "Page  of"
            }
        }
    ]
}